21716591

Source:http://linkedlifedata.com/resource/pubmed/id/21716591

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0085415, umls-concept:C0206526, umls-concept:C0282386, umls-concept:C0536495, umls-concept:C1514923, umls-concept:C1707455
pubmed:issue	2
pubmed:dateCreated	2011-6-30
pubmed:abstractText	To compare the effect of levofloxacin and moxifloxacin on treatment outcomes among patients with multidrug-resistant tuberculosis (MDR-TB).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-10553700, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-10713001, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-11217874, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-11286786, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-12543673, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-12588714, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-12758200, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-12837348, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-14506018, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-14555582, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-14962530, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-14982764, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-15664227, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-15971391, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-16707517, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-16776446, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-16837502, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-16916327, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-17145798, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-17883288, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-17968823, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-19075046, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-19251799, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-7574527, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-8807049, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-8849750, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-9687408, http://linkedlifedata.com/resource/pubmed/commentcorrection/21716591-9869570
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8712418
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents, http://linkedlifedata.com/resource/pubmed/chemical/Aza Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Ofloxacin, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/moxifloxacin
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	2005-6648
pubmed:author	pubmed-author:ChungHee SoonHS, pubmed-author:HanSung KooSK, pubmed-author:KimDeog KyeomDK, pubmed-author:KimJae YeolJY, pubmed-author:KimYoung WhanYW, pubmed-author:LeeChang-HoonCH, pubmed-author:LeeChoon-TaekCT, pubmed-author:LeeJae HoJH, pubmed-author:LeeJinwooJ, pubmed-author:LeeSang-MinSM, pubmed-author:YangSeok-ChulSC, pubmed-author:YimJae-JoonJJ, pubmed-author:YooChul-GyuCG, pubmed-author:YoonHo IlHI
pubmed:issnType	Electronic
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	153-9
pubmed:meshHeading	pubmed-meshheading:21716591-Adult, pubmed-meshheading:21716591-Antitubercular Agents, pubmed-meshheading:21716591-Aza Compounds, pubmed-meshheading:21716591-Case-Control Studies, pubmed-meshheading:21716591-Chi-Square Distribution, pubmed-meshheading:21716591-Drug Resistance, Multiple, Bacterial, pubmed-meshheading:21716591-Drug Therapy, Combination, pubmed-meshheading:21716591-Extensively Drug-Resistant Tuberculosis, pubmed-meshheading:21716591-Female, pubmed-meshheading:21716591-Humans, pubmed-meshheading:21716591-Logistic Models, pubmed-meshheading:21716591-Male, pubmed-meshheading:21716591-Middle Aged, pubmed-meshheading:21716591-Mycobacterium tuberculosis, pubmed-meshheading:21716591-Odds Ratio, pubmed-meshheading:21716591-Ofloxacin, pubmed-meshheading:21716591-Quinolines, pubmed-meshheading:21716591-Recurrence, pubmed-meshheading:21716591-Remission Induction, pubmed-meshheading:21716591-Republic of Korea, pubmed-meshheading:21716591-Retrospective Studies, pubmed-meshheading:21716591-Risk Assessment, pubmed-meshheading:21716591-Risk Factors, pubmed-meshheading:21716591-Time Factors, pubmed-meshheading:21716591-Treatment Outcome, pubmed-meshheading:21716591-Tuberculosis, Multidrug-Resistant
pubmed:year	2011
pubmed:articleTitle	Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.
pubmed:affiliation	Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Korea.
pubmed:publicationType	Journal Article, Comparative Study